脊髓切除术后门静脉血栓形成的长期预防性抗凝药:系统性审查和元分析
Zheng Liao1, Zixiang Wang1, Chenguang Su1
1Department of Hepatobiliary Surgery, Affiliated Hospital of Chengde Medical University, Chengde, Hebei, China.
PloS one
|August 15, 2023
概括
华法林等抗凝固药物显著降低了门静脉系统血栓形成 (PVST) 在脊髓灰质炎患者的脊髓灰质炎后. 六个月的华法林是最佳的,而不会增加出血风险.
科学领域:
- 肝病学和胃肠病学 肝病学和胃肠学
- 血管外科 血管外科
- 药理学 药理学是指药理学的学科.
背景情况:
- 门静脉系统血栓塞 (PVST) 是脊髓切除术后肝硬化患者的一个重大并发症.
- 有效的预防策略对于改善患者治疗结果至关重要.
研究的目的:
- 评估抗凝剂在预防脊髓炎患者脊髓切除术后PVST的疗效和安全性.
- 为了确定抗凝剂的最佳持续时间.
主要方法:
- 在PubMed,Embase和CBM数据库的系统文献搜索.
- 包括8项研究 (6项观察性,2项随机试验) 涉及592名受试者.
- 对PVST发生率和术后出血率的分析.
主要成果:
- 抗凝剂的使用显著减少了在脊髓切除术后的前6个月内PVST的发生率.
- 术后3个月和6个月发生的PVST最显著的减少.
- 在抗凝剂组中没有观察到出血风险的显著增加.
结论:
- 低分子量肝素 (LMWH) 和华法林有效降低脊髓切除术后肝硬化患者的PVST.
- 这些抗凝剂不会增加出血的风险.
- 6个月的华法林治疗被认为是治疗的最佳持续时间.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Esophageal Varices-II: Clinical Features and Management
96
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
96
Venous Thrombosis IV: Nursing Management
14
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
14
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
Esophageal Varices-I: Introduction
183
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
183
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K


